Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2025.03.002 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Ying Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China; Sichuan University-Oxford U…. Hauptthemen laut MEDLINE: Gastrointestinal Contents, Glucagon-Like Peptide-1 Receptor Agonists, Respiratory Aspiration. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Glucagon-like peptide-1 receptor agonists (GLP1-RA) are associated with increased residual gastric content (RGC); however, there is debate about their impact on RGC-related clinical outcomes, particularly aspiration. METHODS: PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched for studies published up to January 4, 2025, comparing GLP1-RA with control groups (non-GLP1-RA) in patients undergoing endoscopy. The outcomes of interest included the risk of RGC, pulmonary aspiration, interrupted and repeated endoscopic procedures, and delays in gastric transit time during capsule endoscopy. For the meta-analysis, a random-effects model was used to calculate the pooled odds ratio (OR) and mean difference (MD) with 95 % confidence intervals (CIs). RESULTS: Thirty-nine studies composed of a total of 1,253,498 subjects, were included. The pooled analysis demonstrated that the GLP1-RA group had a significantly increased risk of RGC (OR 4.86, 95 % CI 3.85-6.14; adjusted OR 5.24, 95 % CI 3.49-7.87), pulmonary aspiration (OR 2.29, 95 % CI 1.36-3.87), interrupted endoscopic procedures (OR 3.22, 95 % CI 1.65-6.29), repeated endoscopy (OR 2.16, 95 % CI 1.14-4.11), and delays in gastric transit time during capsule endoscopy (MD 45.51, 95 % CI 1.33-89.68). CONCLUSIONS: GLP1-RA use increased the risk of RGC, pulmonary aspiration, interrupted and repeated endoscopy and gastric transit time, reducing the safety and completion of upper endoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China; Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital of…
- Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China; Department of Pathology, West China Hospital of Sichuan University, C…
Förderung
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Tan, Y., Zhang, X., Lv, X. H., Sun, Y. N., Yang, J. L., & Xiao, X. (2025). Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.03.002
Vancouver
Tan Y, Zhang X, Lv XH, Sun YN, Yang JL, Xiao X. Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.03.002
BibTeX
@article{Tan2025,
author = {Tan, Ying and Zhang, Xian and Lv, Xiu-He and Sun, Yi-Ning and Yang, Jin-Lin and Xiao, Xue},
title = {Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2025.03.002}
}
EUVIMED